Ten Most Important Things to Know About Caring for Transgender Patients

被引:31
作者
Chipkin, Stuart R. [1 ,2 ]
Kim, Fred [3 ]
机构
[1] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA
[2] Valley Med Grp, Amherst, MA USA
[3] Valley Med Grp, Florence, MA USA
关键词
Cross-sex hormone therapy; Female to male; Male to female; Transgender; Transsexual; SEX HORMONE-TREATMENT; TRANSSEXUAL SUBJECTS; VENOUS THROMBOEMBOLISM; POSTMENOPAUSAL WOMEN; ANDROGEN DEFICIENCY; MORTALITY; THERAPY; HEALTH; CANCER; MEN;
D O I
10.1016/j.amjmed.2017.06.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transgender people have a gender that is not in agreement with their birth sex. Previous barriers, including lack of provider knowledge, have created significant healthcare disparities for this population. Recent societal changes are increasing the numbers of transgender people seen by primary care practitioners. Ten key principles are provided to help primary care practitioners create more welcoming environments and provide quality care to transgender patients. Overall, all members of the healthcare team (primary and specialty) need to become aware of the transition process and maintain communication regarding risks, benefits, and goals. Transwomen (aka male to female) can be treated with estrogens, antiandrogens, or a combination. Benefits include change in fat distribution, skin softening, and breast development. Significant risks for thrombosis from estrogens have been linked to genetic mutations, smoking, prolonged inactivity, and hormone formulation. Oral administration may provide increased risk over peripheral administration. Transmen (aka female to male) can be treated with peripheral testosterone preparations. Benefits include deepening of voice and development of facial and body hair with variable changes in muscle mass. Risks from testosterone appear to be less common than from estrogen. Laboratory monitoring can guide treatment decisions and provide early detection of some complications. Monitoring of "existing" anatomy (either hormonally or surgically created or removed) is an important component of healthcare for transgender patients. Primary care providers also should be aware of resources in their community and online, which can help patients optimize their transition. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1238 / 1245
页数:8
相关论文
共 39 条
[1]   SOME ASPECTS OF INTERACTION BETWEEN NATURAL AND SYNTHETIC FEMALE SEX HORMONES AND LIVER [J].
ADLERCREUTZ, H ;
TENHUNEN, R .
AMERICAN JOURNAL OF MEDICINE, 1970, 49 (05) :630-+
[2]   FOCAL NODULAR HYPERPLASIA OF LIVER ASSOCIATED WITH HIGH-DOSAGE ESTROGENS [J].
ALDINGER, K ;
BENMENACHEM, Y ;
WHALEN, G .
ARCHIVES OF INTERNAL MEDICINE, 1977, 137 (03) :357-359
[3]   Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol [J].
Arnold, Justin D. ;
Sarkodie, Eleanor P. ;
Coleman, Megan E. ;
Goldstein, Deborah A. .
Journal of Sexual Medicine, 2016, 13 (11) :1773-1777
[4]   Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review [J].
Asscheman, H. ;
T'Sjoen, G. ;
Lemaire, A. ;
Mas, M. ;
Meriggiola, M. C. ;
Mueller, A. ;
Kuhn, A. ;
Dhejne, C. ;
Morel-Journel, N. ;
Gooren, L. J. .
ANDROLOGIA, 2014, 46 (07) :791-795
[5]   MORTALITY AND MORBIDITY IN TRANSSEXUAL PATIENTS WITH CROSS-GENDER HORMONE-TREATMENT [J].
ASSCHEMAN, H ;
GOOREN, LJG ;
EKLUND, PLE .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (09) :869-873
[6]   A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones [J].
Asscheman, Henk ;
Giltay, Erik J. ;
Megens, Jos A. J. ;
de Ronde, W. ;
van Trotsenburg, Michael A. A. ;
Gooren, Louis J. G. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (04) :635-642
[7]   Sexual Health of Trans Men Who Are Gay, Bisexual, or Who Have Sex with Men: Results from Ontario, Canada [J].
Bauer, Greta R. ;
Redman, Nik ;
Bradley, Kaitlin ;
Scheim, Ayden I. .
INTERNATIONAL JOURNAL OF TRANSGENDERISM, 2013, 14 (02) :66-74
[8]   Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline [J].
Bhasin, Shalender ;
Cunningham, Glenn R. ;
Hayes, Frances J. ;
Matsumoto, Alvin M. ;
Snyder, Peter J. ;
Swerdloff, Ronald S. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06) :2536-2559
[9]   Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 [J].
Coleman, E. ;
Bockting, W. ;
Botzer, M. ;
Cohen-Kettenis, P. ;
DeCuypere, G. ;
Feldman, J. ;
Fraser, L. ;
Green, J. ;
Knudson, G. ;
Meyer, W. ;
Monstrey, S. ;
Adler, R. ;
Brown, G. ;
Devor, A. ;
Ehrbar, R. ;
Ettner, R. ;
Eyler, E. ;
Garofalo, R. ;
Karasic, D. ;
Lev, A. ;
Mayer, G. ;
Meyer-Bahlburg, H. ;
Hall, B. ;
Pfaefflin, F. ;
Rachlin, K. ;
Robinson, B. ;
Schechter, L. ;
Tangpricha, V. ;
van Trotsenburg, M. ;
Vitale, A. ;
Winter, S. ;
Whittle, S. ;
Wylie, K. ;
Zucker, K. .
INTERNATIONAL JOURNAL OF TRANSGENDERISM, 2012, 13 (04) :165-232
[10]   Transgender Demographics: A Household Probability Sample of US Adults, 2014 [J].
Crissman, Halley P. ;
Berger, Mitchell B. ;
Graham, Louis F. ;
Dalton, Vanessa K. .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2017, 107 (02) :213-215